Aster DM Healthcare has announced an interim dividend of ₹3 per share for the financial year 2025-26. The record date for determining shareholder entitlement is set for April 3, 2026.
On March 26, 2026, Aster DM Healthcare's Board of Directors declared an interim dividend of ₹3 per share for the financial year ending March 31, 2026.
The shares are fully paid and have a face value of ₹10 each. The record date for determining the entitlement of shareholders to this interim dividend is April 3, 2026.
The dividend will be disbursed to shareholders within 30 days from the date of declaration, ensuring timely payments. This announcement follows the company's commitment to rewarding its shareholders.
In accordance with the Finance Act 2020, dividend income is taxable in the hands of shareholders from April 1, 2020. Consequently, the interim dividend will be paid after deducting tax at source (TDS) as per the Income Tax Act, 1961.
Shareholders are advised to submit the necessary documents by April 6, 2026, to facilitate the determination of applicable TDS rates.
Aster DM Healthcare will communicate further details to shareholders regarding the tax deduction process in due course. This ensures compliance with tax regulations and provides clarity to shareholders on their net dividend income.
The Board of Directors' meeting, where the interim dividend was declared, commenced at 2:00 PM and concluded at 2:15 PM IST on March 26, 2026.
This brief meeting underscores the efficiency and decisiveness of the company's leadership in making timely decisions for shareholder benefit.
As of March 25, 2026, at 3:30 PM, Aster DM Healthcare share price on NSE was closed at ₹652.00 up by 2.86% from the previous closing price.
Aster DM Healthcare's declaration of a ₹3 interim dividend for FY 2025-26 reflects its ongoing commitment to shareholder value. With a clear record date and tax compliance measures in place, the company ensures a smooth dividend distribution process.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Mar 27, 2026, 8:23 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
